Authors
Loading...
Comparative analysis highlights PREVENT's advantages for short-term ASCVD risk and limitations for long-term assessment.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: